Alzheimer's Drug Discovery Foundation: Advancing Research on Care and Outcome Measurements (ARCOM)- (LOI)

שם: Alzheimer's Drug Discovery Foundation: Advancing Research on Care and Outcome Measurements (ARCOM)- (LOI)
תאריך הגשה: 05/05/21
לאתר הקול הקורא
תיאור כללי:

The Association has identified a number of important focus areas within five broad categories: (1) social and behavioral features; (2) clinical investigations; (3) basic biology; (4) adaptive technology; and (5) cognitive functional studies.

Areas of interest include but are not limited to:

  • Outcome measurement, such as the development of new person-centered outcome measures that foster a constructive balance between strength and deficit assessment
  • Care measurement, such as the development of measures to guide care that is known to result in positive outcomes.
  • Application of measurement, such as use of measures in new settings, with new populations, or in novel applications.
  • Evaluation of measurement in intervention research

Funding: up to $250,000 (direct and indirect costs 10%) over 2 years. Nonprofit.

https://www.alz.org/research/for_researchers/grants/types-of-grants/advancing-research-on-care-and-outcome-measurement

מקור: זר
תקציב: up to $250,000
מס' שנים למחקר: 2
איש קשר: Robi, 2152, robertg@trdf.technion.ac.il; iris 1272, irisbr@campus.technion.ac.il
תחומים: מדעי החיים ורפואה
סוג הקרן: הקרן אינה קרן תחרותית.
קרן ופרופילים משויכים: Alzheimer’s Drug Discovery Foundation - ADDF ,פתוח לחברי סגל הטכניון בלבד. אנא התחבר\י כדי לצפות בפרופילי המימון של הקרן (בפינה הימנית העליונה).